Company Filing History:
Years Active: 1998-2001
Title: Yu-Hui Rogers: Innovator in Nucleotide Sequencing and Array Printing
Introduction
Yu-Hui Rogers is a prominent inventor based in Damascus, MD (US). She has made significant contributions to the fields of molecular biology and biotechnology, particularly in nucleotide sequencing and array printing technologies. With a total of 4 patents, her work has advanced the methods used in genetic analysis and molecular diagnostics.
Latest Patents
One of her latest patents is titled "Method for analyzing the nucleotide sequence of a polynucleotide by oligonucleotide extension on an array." This invention provides a method for determining the nucleotide sequence of a nucleic acid molecule using primer oligonucleotides arrayed on a solid support. By utilizing both hybridized and non-hybridized oligonucleotide primers, the invention reduces the number of primers needed to fully sequence a nucleic acid molecule. Additionally, the invention offers kits that facilitate the implementation of these methods.
Another notable patent is for "Gene pen devices for array printing." This invention concerns an apparatus for printing arrays of molecules, specifically a gene pen apparatus that delivers arrays of oligonucleotides on solid supports from multiple reagent reservoirs. The flow controlling means can be either a pin valve or a wicking mechanism, enhancing the efficiency of array printing.
Career Highlights
Throughout her career, Yu-Hui Rogers has worked with various companies, including Orchid Biosciences, Inc. and Molecular Tool, Inc. Her innovative approaches have positioned her as a key figure in the development of advanced molecular tools.
Collaborations
Yu-Hui has collaborated with notable professionals in her field, including Michael T Boyce-Jacino and Stephen P Anderson. These collaborations have further enriched her research and development efforts.
Conclusion
Yu-Hui Rogers is a trailblazer in the realm of nucleotide sequencing and array printing technologies. Her inventions continue to impact the scientific community and advance the capabilities of molecular diagnostics.